Package 69097-642-02

{"route": ["ORAL"], "spl_id": "ac668220-d696-48b3-86f7-05509ba90805", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["G70B4ETF4S"], "rxcui": ["403875"], "spl_set_id": ["a229c922-58eb-4795-9219-6cebb1779e35"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (69097-642-02)", "package_ndc": "69097-642-02", "marketing_start_date": "20200831"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (69097-642-15)", "package_ndc": "69097-642-15", "marketing_start_date": "20200831"}], "brand_name": "emtricitabine", "product_id": "69097-642_ac668220-d696-48b3-86f7-05509ba90805", "dosage_form": "CAPSULE", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "69097-642", "generic_name": "emtricitabine", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "emtricitabine", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}], "application_number": "ANDA091168", "marketing_category": "ANDA", "marketing_start_date": "20200831", "listing_expiration_date": "20261231"}